NEW YORK (GenomeWeb) – German molecular diagnostics firm Epigenomics today reported that its second quarter revenues increased 20 percent year over year on higher product revenues.

The firm reported revenues of €487,000 ($532,096) versus revenues of €405,000 for the second quarter of 2015. The company said that its product revenues increased 36 percent to €289,000 versus €212,000 in the prior-year period.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.